Regenxbio Inc (NAS:RGNX)
$ 9.92 -0.09 (-0.9%) Market Cap: 491.49 Mil Enterprise Value: 320.09 Mil PE Ratio: 0 PB Ratio: 1.63 GF Score: 65/100

Q2 2024 Regenxbio Inc Earnings Call Transcript

Aug 01, 2024 / 08:30PM GMT
Release Date Price: $13.31 (-6.60%)
Operator

Welcome everyone to the Q2 2024 Regenxbio earnings conference call. (Operator Instructions)

At this time, I'd like to the conference over to Patrick Christmas, Chief Legal Officer of Regenxbio. Please go ahead.

Patrick Christmas
Regenxbio Inc - Executive Vice President, Chief Legal Officer

Good afternoon, and thank you for joining us today. Earlier this afternoon. Regeneron bio released financial and operating results for the second quarter ended June 30th, 2020. For the press release is available on our website at www.regenxbio.com.

Today's conference call will include forward-looking statements regarding our financial outlook in addition to regulatory and product development plans. These forward-looking statements are subject to risks and uncertainties that may cause actual results to differ from those forecasted. It can be identified by words such as expect, plan, will, may, anticipate, believe, should, intend and other words of similar meaning any such forward-looking

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot